EP2788001
NASAL FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
4.12.2012EP published:
2.12.2015EP application number:
12797884.9
EPO information:
European Patent Register
Max expiry date:
3.12.2032
Title:
NASAL FORMULATION
Timeline
Today
4.12.2012EP application
2.12.2015EP Publication
Owner
Name:
Teva Branded Pharmaceutical Products R & D, Inc.Address:
41 Moores Road, 19355, Frazer, Pennsylvania, US
Inventor
Name:
ZENG, Xian-MingAddress:
Miami, Florida, US
Name:
LY, Jade Ching-YingAddress:
Miami, Florida, US
Name:
DALVI, Mukul CAddress:
Miami, Florida, US
Priority
Number:
201161567893 PDate:
7.12.2011Country:
US
Number:
201121812Date:
19.12.2011Country:
GB
Classification
Categories:
A61K 31/55, A61K 31/573, A61K 9/00, A61K 9/12, A61M 11/04, A61M 11/06, A61M 15/00, A61M 15/08, A61P 27/14